Medicine, Gastroenterology Division

Feinberg School of Medicine, Feinberg Clinical

91 Grants

The grant details show the name of the PI, active dates of the project, the sponsor, and the abstract of the grant or award (if available). A Fingerprint is created using any available content from the grant, including title and abstract where available. The sources of the grant and award information are the Northwestern University InfoEd database and the grants databases at Children’s Memorial Hospital and the Rehabilitation Institute of Chicago.

• 1.

  Ikuo Hirano; Nirmala Prabu Gonsalves

  Prot # MPI-101-06. Oral Budesonide Suspension (OBS) In Adolescent and Young Adult Subjects (12-25 Years Of Age) With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With An Open-Label Extension

  9/13/2012 - 9/13/2015

  Document ID: Prot#MPI-101-06

  Sponsor: Synteract, Inc.

• 2.

  Terrence Barrett; Navdeep Chandel; Tatiana Goretsky; Rebecca Katzman; David Williams

  Regulation of Intestinal Stem Cell Activation in Colitis

  9/1/2012 - 6/30/2016

  Document ID: 2R01DK095662-06A1

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 3.

  Michael Messod Abecassis; Terrence Barrett; Jane Holl

  Transplant Surgery Scientist Training Program

  7/1/2012 - 6/30/2017

  Document ID: 2T32DK077662-06

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 4.

  Laurie Keefer; John Pandolfino; Peter Kahrilas; Zoran Martinovich

  Defining Clinically Relevant Phenotypes of PPI Non-Responders

  4/1/2012 - 3/31/2015

  Document ID: 1R01DK092217-01A1

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 5.

  Ikuo Hirano; Nirmala Prabu Gonsalves

  Prot# PR-022: A Six Month, Safety Follow-up Study in Subjects with Eosinophilic Esophagitis (EoE) who Completed Study PR-021 [PR-021: A multicenter, randomized, double-blind, placebo-controlled, safety and tolerability phase 1/2a study of two dosing regimens of EUR-1100 for oral use, in subjects with eosinophilic esophagitis (EoE)]

  3/30/2012 - 3/30/2015

  Document ID: PR-022

  Sponsor: Medpace, Inc.

• 6.

  Laurie Keefer

  Online Patient Self-Assessment for Chronic Pancreatic and Other Pain

  2/1/2012 - 1/31/2013

  Document ID: Agmt3.28.12//R43DK092097

  Sponsor: CPM Systems, Inc.

• 7.

  Ikuo Hirano; Nirmala Prabu Gonsalves

  Prot# PR-021: A Multicenter, Randomized, Double-blind, Placebo-controlled, Safety and Tolerability Phase 1/2a Study of Two Dosing Regimens of EUR-1100 for Oral Use, In Subjects With Eosinophilic Esophagitis (EoE)"

  1/26/2012 - 1/26/2015

  Document ID: PR-021

  Sponsor: Medpace, Inc.

• 8.

  David Baker; Kenzie Cameron; Maria Rosario Ferreira; Alfred Rademaker; Michael Wolf

  NU Center for Advancing Equity in Clinical Preventive Services

  9/30/2011 - 9/29/2014

  Document ID: P01HS021141

  Sponsor: Agency for Healthcare Research and Quality

• 9.

  David Baker; Helen Binns; Joseph Feinglass; Michael Fleming; Dana Gossett; Romana Hasnain-Wynia; Namratha Kandula; Abel Kho; Larry Michael Manheim; Kenzie Cameron; Jermaine Dellahousaye; Maria Rosario Ferreira; Eric Henley; Muriel Jean-Jacques; Erin Kaleba; Donald Lloyd-Jones; Timothy Long; Stephen Persell; Fred Rachman; Alfred Rademaker; Nathan Taylor; Michael Wolf

  NU Center for Advancing Equity in Clinical Preventive Services

  9/30/2011 - 9/29/2014

  Document ID: P01HS021141

  Sponsor: Agency for Healthcare Research and Quality

• 10.

  Nirmala Prabu Gonsalves

  Molecular basis of food allergy and food tolerance

  9/30/2011 - 9/29/2012

  Document ID: W960155RSUB//81XWH-10-GSFARP-IA

  Sponsor: Children's Hospital of Philadelphia

• 11.

  Ikuo Hirano; Nirmala Prabu Gonsalves

  Prot# ZM6497A: Development of a Symptom Assessment of Adolescent and Adult Eosinophilic Esophagitis and Field Study

  7/28/2011 - 7/28/2014

  Document ID: ZM6497A

  Sponsor: Meritage Pharma, Inc.

• 12.

  Peter Kahrilas; Monika Kwiatek; John Pandolfino

  The Esophagogastric Junction in Health and Disease

  6/25/2011 - 8/31/2016

  Document ID: R01DK056033

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 13.

  Terrence Barrett

  The Role of the IL-1 Receptor in Colitis-Induced Intestinal Epithelial Cell Beta-Catenin Activation and Proliferation

  6/15/2011 - 8/31/2011

  Document ID: CCFA3429

  Sponsor: Crohn's and Colitis Foundation of America

• 14.

  Ikuo Hirano

  Registry for Eosinophilic Gastrointestinal Disorders (REDGID)

  5/20/2011 - 5/19/2012

  Document ID: agrtdtd08172011

  Sponsor: Cincinnati Children's Hospital Medical Center

• 15.

  Ikuo Hirano; Nirmala Prabu Gonsalves

  Agmt 4/4/11: Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index: A Prospective Multicenter Study

  4/4/2011 - 4/4/2014

  Document ID: Agmt4/4/11

  Sponsor: University of Bern

• 16.

  Paul Bryce; Nirmala Prabu Gonsalves; Ikuo Hirano

  Mechanisms of Eosinophilic Esophagitis in Adults

  4/1/2011 - 3/31/2013

  Document ID: agrmnt5/5/11

  Sponsor: Sunshine Charitable Foundation

• 17.

  Barbara Jung

  Activin Signaling and Regulation in the Colon

  9/27/2010 - 7/31/2015

  Document ID: R01CA141057

  Sponsor: National Cancer Institute

• 18.

  Colin Howden; Darren Brenner; Laura Yun

  Antidepressent Therapy for Functional Dyspepsia

  8/1/2010 - 7/31/2011

  Document ID: agrmnt2/18/11//U01DK065713

  Sponsor: Mayo Clinic

• 19.

  Terrence Barrett

  Jonathan Kammo fellowship in support of Identification of the Intestinal Epithelial Cells with Inflammation-Induced Beta-Catenin Transcriptional Activation and Prevention Thereof by Proteasome Inhibition

  6/15/2010 - 9/1/2010

  Document ID: CCFARef.#2897

  Sponsor: Crohn's and Colitis Foundation of America

• 20.

  Terrence Barrett

  Catherine Tan Fellowship in Support of Metformin Affects Stem Cell Activation in Colitis

  6/15/2010 - 9/1/2010

  Document ID: CCFA#2900

  Sponsor: Crohn's and Colitis Foundation of America

• 21.

  Ikuo Hirano; Christine Nelson

  Prot# ZM6278A: Qualitative Research and Validation Program for the Assessment of Dysphagia Symptoms in Adults with Eosinophilic Esophagitis

  5/18/2010 - 5/18/2013

  Document ID: ZM6278A

  Sponsor: Meritage Pharma, Inc.

• 22.

  Cindy Zadikoff; Tatyana Simuni; Arvydas Vanagunas; Aleksandar Videnovic

  Prot#S187.3.005: Open- Label Continuation Treatment, Study With Levodopa-Carbidopa Intestinal Gel in Subjects With Advanced Parkinsons Disease And Severe Motor Fluctuations Who Have Exhibited A Persistent And Positive Effect To Treatment In Previous Studies

  2/1/2010 - 1/31/2016

  Document ID: S187.3.005

  Sponsor: Quintiles, Inc.

• 23.

  Terrence Barrett; Elias Gounaris; Khashayarsha Khazaie

  Use of Fluorescent Molecular Probes to Detect Dyspasia in Colorectal Cancer Screening

  1/1/2010 - 8/31/2012

  Document ID: AgremtEAM222

  Sponsor: Northwestern Memorial Hospital

• 24.

  Ikuo Hirano; Nirmala Prabu Gonsalves

  PROT# CQAX576A2205: A Double-Blinded, Randomized, Placebo-Controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis

  11/2/2009 - 7/31/2011

  Document ID: PROT#CQAX576A2205

  Sponsor: Novartis Pharmaceuticals Corporation

• 25.

  Cindy Zadikoff; Tatyana Simuni; Arvydas Vanagunas; Aleksandar Videnovic

  Protocol S187.3.003: Open Label, 12 Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects

  10/8/2009 - 10/7/2015

  Document ID: S187.3.003

  Sponsor: Quintiles, Inc.

• 26.

  Kenzie Cameron; Nancy Dolan; Maria Rosario Ferreira; Larry Michael Manheim; Alfred Rademaker; Michael Wolf

  Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening

  9/4/2009 - 7/31/2013

  Document ID: R01CA140177

  Sponsor: National Cancer Institute

• 27.

  Cindy Zadikoff; Tatyana Simuni; Arvydas Vanagunas; Aleksandar Videnovic

  Prot# S187.3.002: A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestina Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments with Parkinson Medicinal Products, Who Continue to Experience Persistent Motor Fluctuations

  8/6/2009 - 8/5/2015

  Document ID: Prot#S187.3.002

  Sponsor: Quintiles, Inc.

• 28.

  John Pandolfino; Ikuo Hirano; Peter Kahrilas; Monika Kwiatek; Alfred Rademaker

  The Mechanics of Symptom Generation in Dysphagia

  7/1/2009 - 6/30/2014

  Document ID: R01DK079902

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 29.

  Terrence Barrett

  Fellowship in support of Analysis of 5-ASA Regulation of PI3K/Beta-Catenin Signaling in the Colon

  6/15/2009 - 8/31/2009

  Document ID: 2479

  Sponsor: Crohn's and Colitis Foundation of America

• 30.

  Terrence Barrett

  Fellowship in support of The Role of PI3K in Small Bowel Polyposis

  6/15/2009 - 8/31/2009

  Document ID: 2495

  Sponsor: Crohn's and Colitis Foundation of America

• 31.

  Terrence Barrett

  Fellowship in support of The Role of PI3K in Activating Beta-Catenin Signaling During DSS Colitis

  6/15/2009 - 8/31/2009

  Document ID: 2493

  Sponsor: Crohn's and Colitis Foundation of America

• 32.

  Terrence Barrett

  Fellowship in support of Examination of Beta Catenin Signaling in Human Biopsies

  6/15/2009 - 8/31/2009

  Document ID: 2494

  Sponsor: Crohn's and Colitis Foundation of America

• 33.

  John Pandolfino; Ikuo Hirano; Colin Howden; Peter Kahrilas

  Prot# D9120C00027: Validation of Patient-Reported Outcome Measures for the Assessment of GERD Symptoms and Their Subsequent Impact on Patients with a Partial Response to PPI Treatment in a Two Part Multi-Center Phase IIA Study Including a Four Week Randomised, Double-Blind, Placebo-Controlled Parallel-Group Treatment Period with AZD3355, 65 mg Bid as Add-On Treatment to a PPI

  10/20/2008 - 10/20/2011

  Document ID: D9120C00027

  Sponsor: AstraZeneca Pharmaceuticals LP

• 34.

  Anthony Schaeffer; Apkar Apkarian; Colleen Fitzgerald; Laurie Keefer; Todd Parrish

  Interactive Mechanisms of Pelvic Pain

  9/15/2008 - 6/30/2013

  Document ID: 5U01DK082342-05

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 35.

  Richard Gershon; David Klumpp; Anthony Schaeffer; Apkar Apkarian; David Cella; Colleen Fitzgerald; James Griffith; CJ Heckman; Mingchen Jiang; Laurie Keefer; Todd Parrish; Praveen Thumbikat

  Interactive Mechanisms of Pelvic Pain

  9/15/2008 - 6/30/2013

  Document ID: 5U01DK082342-05

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 36.

  Cindy Zadikoff; Tatyana Simuni; Arvydas Vanagunas; Aleksandar Videnovic

  Prot# S187.3.004: Open-Label, 6-12 Months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations

  7/11/2008 - 7/11/2011

  Document ID: S187.3.004

  Sponsor: Quintiles, Inc.

• 37.

  David Baker; Kenzie Cameron; Maria Rosario Ferreira; Denise Scholtens; Michael Wolf

  Tools for Improving Colorectal Cancer Screening Rates: Multimedia vs. Print

  7/1/2008 - 6/30/2012

  Document ID: RSGT-08-149-01-CPPB//S0646-SC1-20

  Sponsor: Saint Francis Hospital and Medical Center

• 38.

  Terrence Barrett

  An Orally-Delivered Multiantigen Vaccine for the Prevention of Breast Cancer Relapse

  6/30/2008 - 6/29/2010

  Document ID: Agreement10/21/08

  Sponsor: Mayo Clinic

• 39.

  Terrence Barrett

  Examination of Beta Catenin Signaling in IBD

  6/15/2008 - 6/14/2009

  Document ID: AwardLetter5/13/08

  Sponsor: Crohn's and Colitis Foundation of America

• 40.

  Terrence Barrett; Kaitlin Wanta

  Growth Factor Induced Stem Cell Activation in Colitis

  6/15/2008 - 6/14/2009

  Document ID: AwardLetter5/13/08

  Sponsor: Crohn's and Colitis Foundation of America

• 41.

  Terrence Barrett; Randolph Winnegar

  The Role of Inositol in Colitis Induced Cancer

  6/15/2008 - 6/14/2009

  Document ID: Letter5/13/08

  Sponsor: Crohn's and Colitis Foundation of America

• 42.

  John Pandolfino; Ikuo Hirano; Eric Hungness; Peter Kahrilas; Monika Kwiatek; Nathaniel Soper

  Measurement of the Compliance of Esophagogastric Junction During Esophagogastroduodenoscopy to Predict Abnormal Esophageal Acid Exposure

  5/16/2008 - 5/16/2011

  Document ID: Agmt05/16/08

  Sponsor: Crospon Ltd.

• 43.

  Laurie Keefer; Michael Jones; Darren Brenner

  Self-administered CBT for IBS: A Multicenter Trial

  5/15/2008 - 4/30/2015

  Document ID: 1071318/2/46627/U01DK077738

  Sponsor: State University of New York at Buffalo

• 44.

  Laurie Keefer; Terrence Barrett; Michael Jones; Zoran Martinovich

  The Role of Gut-Directed Hypnotherapy in Relapse Prevention for Ulcerative Colitis

  4/1/2008 - 3/31/2011

  Document ID: R21AT003204

  Sponsor: National Center for Complementary and Alternative Medicine

• 45.

  Michael Messod Abecassis; Terrence Barrett; Dixon Blake Kaufman

  Transplant Surgery Scientist Training Program

  7/1/2007 - 6/30/2012

  Document ID: 1T32DK077662-01

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 46.

  John Pandolfino

  The Mechanical Basis for Dysphagia

  7/1/2007 - 6/30/2009

  Document ID: Acceptanceletter4/13/07

  Sponsor: Foundation for Digestive Health and Nutrition

• 47.

  Terrence Barrett

  Fellowship Award in Support of Oxidant induced EGF signaling in colitis

  6/15/2007 - 8/15/2007

  Document ID: AwardLetter5/24/07

  Sponsor: Crohn's and Colitis Foundation of America

• 48.

  Peter Kahrilas; Sudip Ghosh; Monika Kwiatek; John Pandolfino

  The Esophagogastric Junction in Health and Disease

  4/15/2007 - 9/22/2011

  Document ID: R01DK056033

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 49.

  Peter Kahrilas; Sudip Ghosh; John Pandolfino; Qing Zhang

  The Esophagogastric Junction in Health and Disease

  9/19/2006 - 3/31/2007

  Document ID: R56DK056033

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 50.

  John Pandolfino; Peter Kahrilas; Thomas Lee

  Prot# IRUSESOM0378: Proximal Extent of the "Acid Pocket" in Asymptomatic Controls and Symptomatic Patients with GERD and Non-ulcer Dyspepsia

  8/28/2006

  Document ID: IRUSESOM0378

  Sponsor: AstraZeneca LP

• 51.

  Jerilyn Logemann; Mark Agulnik; Peter Kahrilas; Bharat Mittal; Jyoti Patel; Harold Pelzer; Barbara Roa Pauloski; Alfred Rademaker

  Oropharyngeal Function After Radiotherapy with IMRT

  7/10/2006 - 6/30/2012

  Document ID: R01DC007659

  Sponsor: National Institute on Deafness and Other Communication Disorders

• 52.

  Colin Howden

  Utilization of Preventive Strategies in Patients Discharged from the Hospital on Ulcerogenic Medications

  6/19/2006

  Document ID: Agmt5/15/06

  Sponsor: AstraZeneca LP

• 53.

  Terrence Barrett

  5ASA-Mediated Inhibition of Intestinal Stem Cells in Colitis-Induced Cancer

  6/14/2006 - 5/31/2008

  Document ID: Agmt6/14/06

  Sponsor: Procter & Gamble Company

• 54.

  Terrence Barrett

  Fellowship in Support of The Role of Inflammation in Colon Cancer

  6/1/2006 - 8/31/2006

  Document ID: CheckNo.078573

  Sponsor: Crohn's and Colitis Foundation of America

• 55.

  Terrence Barrett

  Fellowship in Support of the Effects of 5ASA on Stem Cell Activity

  6/1/2006 - 8/31/2006

  Document ID: CheckNo.080412

  Sponsor: Crohn's and Colitis Foundation of America

• 56.

  Peter Kahrilas

  Gastroenterology Seminar and Grand Rounds

  4/28/2006 - 12/31/2008

  Document ID: Agmt02/10/06

  Sponsor: AstraZeneca LP

• 57.

  Michael Jones; Laurie Keefer

  Stigma in the Irritable Bowel Syndrome (IBS): Development of a Condition-Specific Measure and Relationship to Quality of Life

  3/1/2006 - 10/31/2007

  Document ID: 5-34164//R24DK067674-02

  Sponsor: University of North Carolina at Chapel Hill

• 58.

  Terrence Barrett

  The Role of Anti-TNF Therapy in Preventing Colitis-Induced Cancer

  12/14/2005

  Document ID: Agmt12/14/05

  Sponsor: Centocor, Inc.

• 59.

  Terrence Barrett; Stephen Antonik

  Exploration of the Wnt/Beta-Catenin Pathway in Barrett's Esophagus

  10/1/2005 - 10/1/2006

  Document ID: Agmt10/28/2005

  Sponsor: TAP Pharmaceutical Products Inc.

• 60.

  Elizabeth Ann Calhoun; Steven Rosen; Nancy Dolan; Joseph Feinglass; Maria Rosario Ferreira; June McKoy; Michael Wolf; Dachao Liu; Carla Pugh

  Chicago Cancer Navigation Project

  9/16/2005 - 8/31/2012

  Document ID: U01CA116875

  Sponsor: National Cancer Institute

• 61.

  Colin Howden; Michael Jones

  Antidepressant Therapy for Functional Dyspepsia

  9/15/2005 - 8/31/2012

  Document ID: Agmt.10/21/08//R01DK065713

  Sponsor: Mayo Clinic

• 62.

  Jonathan Paul Fryer; Terrence Barrett; Zheng Jenny Zhang

  Permeability Changes in Small Bowel Allograft Rejection

  8/15/2005 - 6/30/2007

  Document ID: 5R21DK072544-02

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 63.

  John Pandolfino; Ikuo Hirano; Peter Kahrilas

  Clinical Evaluation of The Bravo Wireless pH Monitoring System

  8/15/2005 - 8/14/2006

  Document ID: Agmt8/15/05

  Sponsor: Medtronic, Inc.

• 64.

  Terrence Barrett

  Lymphoepithelial Interaction in IBD

  8/1/2005 - 1/31/2010

  Document ID: R01AI061701

  Sponsor: National Institute of Allergy and Infectious Diseases

• 65.

  Terrence Barrett; Virinjipuram Viswanathan

  Fellowship in Support of The Role of PI3K/Akt Pathway in T Cell-Induced Crypt Cell Apoptosis

  6/1/2005 - 8/31/2005

  Document ID: Check#068504

  Sponsor: Crohn's and Colitis Foundation of America

• 66.

  Terrence Barrett; Brian Pabst

  Fellowship in Support of The Capacity for 5ASA to Prevent Cancer in IBD

  6/1/2005 - 8/31/2005

  Document ID: Checkdated6/23/05

  Sponsor: Crohn's and Colitis Foundation of America

• 67.

  Arvydas Vanagunas; Thomas Lee

  Monitoring Respiratory Rate Based on Tracheal Sounds Using the Androflo? - Respiratory Rate Monitor

  4/4/2005

  Document ID: Agreement4/04/2005

  Sponsor: Andromed Inc.

• 68.

  Terrence Barrett

  Evaluation of Stem Cell Gene Expression in Ulcerative Colitis

  3/1/2005

  Document ID: Letter6/2/05

  Sponsor: Procter & Gamble Company

• 69.

  Michael Jones; Peter Kahrilas

  Evaluation of Duodenal Acid Exposure in Healthy Controls and Patients with Nonulcer Dyspepsia Using a Radiotelemetry pH Monitoring System

  2/24/2005

  Document ID: Agreement02/24/2005

  Sponsor: AstraZeneca Pharmaceuticals LP

• 70.

  John Pandolfino; Ikuo Hirano; Colin Howden; Peter Kahrilas; Thomas Lee

  Prot# D9770C00011: A 4-wk, Randomised, Double-Blind, Multicenter, Dose-Finding Phase IIb Study w/AZD0865 25,50,75mg & Esomeprazole 20mg, Given Orally 1x Daily for the Treatment of GERD w/out Erosive Esophagitis According to the LA Classification in Adult

  10/13/2004

  Document ID: D9770C00011

  Sponsor: ICON Clinical Research

• 71.

  John Pandolfino; Ikuo Hirano; Colin Howden; Peter Kahrilas; Thomas Lee

  Prot# D9770C00012: A Randomised, Double-Blind, Multicentre Dose-Finding Phase IIb Study for up to 8wks' Treatment w/AZD0865 25,50,75mg & Esomeprazole 40mg, Given Orally 1x Daily for the Healing of Erosive Esophagitis in Adult Subjects w/GERD w/Erosive Eso

  10/13/2004

  Document ID: D9770C00012

  Sponsor: ICON Clinical Research

• 72.

  John Pandolfino; Ikuo Hirano; Peter Kahrilas

  Simultaneous Measurement of Esophageal pH Using the Bravo? System and a Conventional Catheter Based pH System: A Validation Study

  7/1/2004 - 12/31/2005

  Document ID: Agreement7/1/2005

  Sponsor: Medtronic, Inc.

• 73.

  John Pandolfino; Peter Kahrilas

  Simultaneous Measurement of Acid Exposure in the Cardia of the Stomach and Esophagus Using a Radiotelemetry pH Monitoring System

  5/24/2004

  Document ID: Agreement4/21/2004

  Sponsor: AstraZeneca LP

• 74.

  Terrence Barrett; Navdeep Chandel; Edwin McDonald IV

  T Cell Activation and Crypt Cell Apoptosis

  4/1/2004 - 3/31/2009

  Document ID: R01DK054778

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 75.

  Terrence Barrett

  T Cell Activation and Crypt Cell Apoptosis

  4/1/2004 - 3/31/2009

  Document ID: R01DK054778

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 76.

  Terrence Barrett; Edwin McDonald IV

  T Cell Activation and Crypt Cell Apoptosis

  4/1/2004 - 3/31/2009

  Document ID: R01DK054778

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 77.

  Terrence Barrett

  T Cell Activation and Crypt Cell Apoptosis

  4/1/2004 - 3/31/2009

  Document ID: R01DK054778

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 78.

  Peter Kahrilas; Ikuo Hirano; John Pandolfino

  Prot# BSC-GERD-2003-01-Rev 1: A Randomized, Prospective, Controlled Study of Enteryx® for the Treatment of Gastroesophageal Reflux Disease (GERD)

  3/22/2004 - 3/21/2010

  Document ID: BSC-GERD-2003-01-Rev1

  Sponsor: Boston Scientific Corporation

• 79.

  Peter Kahrilas; Ikuo Hirano; Thomas Lee; John Pandolfino

  Prot# G010136-01: An Evaluation of the Medtronic Gatekeeper? System in the Treatment of Subjects with Gastroesophageal Reflux Disease (GERD) [Gatekeeper? Reflux Repair System for Reducing Clinical Symptoms Associated with GERD]

  3/10/2004

  Document ID: G010136-01

  Sponsor: Medtronic, Inc.

• 80.

  Peter Kahrilas; Ikuo Hirano; Thomas Lee; John Pandolfino

  Symptom Correlation of ENRD During Ambulatory Esophageal pH Monitoring (RAB-EMR-423)

  2/26/2004

  Document ID: Agmt2/26/04

  Sponsor: Eisai, Inc. and Janssen Pharmaceutica, L.P.

• 81.

  Michael Messod Abecassis; Mary Anne Hummel; Yashpal Kanwar; Zheng Jenny Zhang; Terrence Barrett

  Surgical Studies of CMV Reactivation in Transplantation

  1/1/2004 - 12/31/2008

  Document ID: R01AI042898

  Sponsor: National Institute of Allergy and Infectious Diseases

• 82.

  Terrence Barrett

  The Role of High Dose 5ASA in Prevention of Colorectal Cancer in IBD

  10/23/2003 - 4/1/2006

  Document ID: Agreement10/23/2003

  Sponsor: Procter & Gamble Company

• 83.

  Peter Kahrilas; Ikuo Hirano; Thomas Lee; John Pandolfino

  Prot# 320-1001: Endoscopic Implantation of Enteryx® for the Treatment of Symptomatic Gastroesophageal Reflux Disease (GERD): Post Market Study

  10/6/2003 - 10/6/2009

  Document ID: 320-1001

  Sponsor: Boston Scientific Corporation

• 84.

  Vadim Backman; Terrence Barrett; Raymond Bergan; Seema Khan; Charles Bennett; Robert Treat Chatterton Jr; Peter Gann; Borko Jovanovic; Sambasiva Musunuri; Ritu Nayar; Michael Pins; Guang-Yu Yang

  Phase I and II Clinical Trials of Cancer Chemopreventive Agents

  9/30/2003 - 9/29/2012

  Document ID: N01-CN-35157

  Sponsor: National Cancer Institute

• 85.

  Terrence Barrett; Raymond Bergan; Sambasiva Musunuri; Guang-Yu Yang

  Phase I and II Clinical Trials of Cancer Chemopreventive Agents

  9/30/2003 - 9/29/2011

  Document ID: N01-CN-35157

  Sponsor: National Cancer Institute

• 86.

  Jeffrey Brown; Terrence Barrett

  The Role of P-Selectin in Effector T-Cell Recruitment to the Colon

  7/1/2003 - 6/30/2010

  Document ID: 900880/A#3/K08DK066161

  Sponsor: Ann & Robert H. Lurie Children's Hospital of Chicago

• 87.

  Terrence Barrett

  The Usefulness of 2'-Deoxycoformycin (DCF) in the Treatment of IBD

  2/24/2003 - 7/31/2005

  Document ID: Ageement02/24/2003

  Sponsor: Astex Pharmaceuticals, Inc.

• 88.

  John Pandolfino

  CAREER: Anatomic and Mechanical Variables of the EGJ in GERD

  7/1/2002 - 6/30/2007

  Document ID: 5K23DK062170-05

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 89.

  Peter Kahrilas; Raymond Joehl; Alfred Rademaker; Guoxiang Shi

  The Esophagogastric Junction in Health and Disease

  4/1/2001 - 8/31/2006

  Document ID: 5R01DK056033-05

  Sponsor: National Institute of Diabetes, Digestive and Kidney Diseases

• 90.

  Colin Howden; Rosalind Van Stolk

  Prot# 122-00: Mltictr, Rndmzd, Prl'l Grp, Placebo-Controlled, Dbl-Bld Study w/ In-House Blinding to Determine the Effect of 156 Weeks of Treatment w/ MK-0966 on Recurrence of Neoplastic Polyps of Large Bowel in Patients w/ a History of Colorectal Adenomas

  5/10/2000 - 4/30/2006

  Document ID: 122-00

  Sponsor: Merck & Co., Inc.

• 91.

  Harry Beaty; Harvey Colten; David Engman; Terrence Barrett; Stephen Miller

  Genetics of Degenerative Neuromuscular Disease and Fundamental Cell and Molecular Biological Mechanisms That Underlie Alzheimer's Disease

  8/15/1996 - 3/31/2002

  Document ID: GRANT96-13

  Sponsor: Lucille P. Markey Charitable Trust